Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate potential effects of valsartan on lipid subfractions
and other parameters in lipid metabolism in patients with essential hypertension and
metabolic syndrome.